Efficacy of a 0.0584% hydrocortisone aceponate spray in presumed feline allergic dermatitis: an open label pilot study
Authors:
- 1 July 2011
- journal article
- clinical trial
- Published by Wiley in Veterinary Dermatology
- Vol. 23 (1) , 11-e4
Abstract
This study evaluated the efficacy of a 0.0584% hydrocortisone aceponate (HCA) spray (Cortavance®; Virbac SA) in 10 cats with presumed allergic dermatitis. The cats initially received two sprays/100 cm2of skin once daily. Clinical lesions (a Feline Dermatitis Extent and Severity Index; FeDESI), pruritus (10 cm visual analog scale with grade descriptors) and owner assessments of efficacy, tolerance and ease of use (from 1 = very poor to 5 = excellent) were assessed every 14 days. The frequency of treatment was reduced after day 28 in cats with a >50% reduction in FeDESI and pruritus scores. One cat was lost to follow up at day 28 and two at day 42. Intention‐to‐treat data were analysed. The FeDESI [mean (SD): day 0, 42.2 (15.7) and day 56, 9.9 (11.7);P < 0.0001] and pruritus scores [day 0, 61.2 mm (20.1) and day 56, 14.6 mm (16.1);P < 0.0001] significantly decreased throughout the trial. The owner scores for tolerance [median (range): day 14, 4 (1–5) and day 56, 4 (3–5);P = 0.003] and ease of administration [day 14, 3 (2–5) and day 56, 4 (2–5);P = 0.02] significantly increased during the trial, but there was no significant change in efficacy scores [day 14, 4 (3–5) and day 56, 4 (2–5);P = 0.5]. There were no adverse effects attributable to the HCA spray, no significant changes in weight [mean (SD): day 0, 5.0 kg (1.4) and day 56, 5.0 kg (1.6);P = 0.51] and no significant changes in haematology, biochemistry or urinalysis (n = 4). Six cats required every‐other‐day treatment and four required daily treatment. In conclusion, HCA spray appeared to be effective and safe in these cats, although it is not licensed for use in this species.Keywords
This publication has 27 references indexed in Scilit:
- Effect of a novel topical diester glucocorticoid spray on immediate- and late-phase cutaneous allergic reactions in Maltese-beagle atopic dogs: a placebo-controlled studyVeterinary Dermatology, 2010
- Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their ownersVeterinary Dermatology, 2010
- Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo‐controlled trialVeterinary Dermatology, 2009
- A review of allergen‐specific immunotherapy in human and veterinary medicineVeterinary Dermatology, 2009
- Development of an owner‐assessed scale to measure the severity of pruritus in dogsVeterinary Dermatology, 2007
- Prospective open pilot study on the use of ciclosporin for feline allergic skin diseaseJournal of Small Animal Practice, 2006
- The use of oral cyclosporin to treat feline dermatoses: a retrospective analysis of 23 casesVeterinary Dermatology, 2006
- A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporin A for feline atopyVeterinary Dermatology, 2004
- Cutaneous reactivity to mosquito bites and its antigens in catsVeterinary Dermatology, 1997
- Allergy Testing for Skin Disease in the CatIn VivovsIn VitroTestsVeterinary Dermatology, 1993